This compound is primarily utilized in pharmacological research due to its structural similarity to serotonin, a key neurotransmitter. It is often explored for its potential interactions with serotonin receptors, making it a candidate for studying mood disorders, anxiety, and depression. Additionally, its trifluoromethoxy group enhances its metabolic stability, which is beneficial in the development of novel therapeutic agents. Researchers also investigate its role in modulating neurochemical pathways, which could lead to advancements in treatments for neurological conditions.